HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services.
mental health
psychiatry
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
19 02 2019
19 02 2019
Historique:
entrez:
21
2
2019
pubmed:
21
2
2019
medline:
25
2
2020
Statut:
epublish
Résumé
Specialised early intervention services have demonstrated improved outcomes in first-episode psychosis (FEP); however, clinical gains may not be sustained after patients are transferred to regular care. Moreover, many patients with FEP remain socially isolated with poor functional outcomes. To address this, our multidisciplinary team has developed a moderated online social media therapy (HORYZONS) designed to enhance social functioning and maintain clinical gains from specialist FEP services. HORYZONS merges: (1) peer-to-peer social networking; (2) tailored therapeutic interventions; (3) expert and peer-moderation; and (4) new models of psychological therapy (strengths and mindfulness-based interventions) targeting social functioning. The aim of this trial is to determine whether following 2 years of specialised support and 18-month online social media-based intervention (HORYZONS) is superior to 18 months of regular care. This study is a single-blind randomised controlled trial. The treatment conditions include HORYZONS plus treatment as usual (TAU) or TAU alone. We recruited 170 young people with FEP, aged 16-27 years, in clinical remission and nearing discharge from Early Psychosis Prevention and Intervention Centre, Melbourne. The study includes four assessment time points, namely, baseline, 6-month, 12-month and 18-month follow-up. The study is due for completion in July 2018 and included a 40-month recruitment period and an 18-month treatment phase. The primary outcome is social functioning at 18 months. Secondary outcome measures include rate of hospital admissions, cost-effectiveness, vocational status, depression, social support, loneliness, self-esteem, self-efficacy, anxiety, psychological well-being, satisfaction with life, quality of life, positive and negative psychotic symptoms and substance use. Social functioning will be also assessed in real time through our Smartphone Ecological Momentary Assessment tool. Melbourne Health Human Research Ethics Committee (2013.146) provided ethics approval for this study. Findings will be made available through scientific journals and forums and to the public via social media and the Orygen website. ACTRN12614000009617; Pre-results.
Identifiants
pubmed: 30782893
pii: bmjopen-2018-024104
doi: 10.1136/bmjopen-2018-024104
pmc: PMC6368148
doi:
Banques de données
ANZCTR
['ACTRN12614000009617']
Types de publication
Clinical Trial Protocol
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e024104Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Front Psychol. 2015 Feb 02;6:15
pubmed: 25698988
Clin Psychol Rev. 2017 Dec;58:59-75
pubmed: 29042139
J Exp Psychol Gen. 2015 Apr;144(2):480-8
pubmed: 25706656
Clin Psychol Rev. 2010 Nov;30(7):849-64
pubmed: 20363063
Schizophr Bull. 2013 Mar;39(2):436-48
pubmed: 22130905
Schizophr Bull. 1996;22(2):305-26
pubmed: 8782288
Schizophr Res. 2018 May;195:448-454
pubmed: 29033282
Schizophr Res. 2010 Jun;119(1-3):79-88
pubmed: 20347266
Lancet Psychiatry. 2018 Jan;5(1):41-50
pubmed: 29242000
Arch Gen Psychiatry. 2008 Jul;65(7):762-71
pubmed: 18606949
J Pers Soc Psychol. 2003 Apr;84(4):822-48
pubmed: 12703651
Schizophr Res. 2012 Aug;139(1-3):116-28
pubmed: 22658527
Soc Psychiatry Psychiatr Epidemiol. 2014 Mar;49(3):359-66
pubmed: 23955376
Br J Psychiatry. 2017 Jul;211(1):37-44
pubmed: 28385705
Schizophr Res. 2001 Aug 1;51(1):55-61
pubmed: 11479066
Schizophr Res. 2014 Jun;156(1):96-106
pubmed: 24746468
Behav Res Ther. 2003 Mar;41(3):317-32
pubmed: 12600402
Schizophr Res. 2013 Jan;143(1):143-9
pubmed: 23146146
Psychiatry Res. 2006 Jun 30;143(1):99-108
pubmed: 16725210
JMIR Ment Health. 2015 May 20;2(2):e18
pubmed: 26543922
Early Interv Psychiatry. 2011 Nov;5(4):360-5
pubmed: 21951752
Psychiatr Clin North Am. 2012 Sep;35(3):735-47
pubmed: 22929876
Soc Psychol Personal Sci. 2013 Sep 1;4(5):
pubmed: 24224070
J Clin Psychiatry. 2009 Apr;70(4):477-86
pubmed: 19323964
Acta Psychiatr Scand. 2007 Dec;116(6):403-18
pubmed: 17941964
Annu Rev Psychol. 2001;52:1-26
pubmed: 11148297
Br J Psychiatry. 2010 Nov;197(5):350-6
pubmed: 21037211
Schizophr Res. 1995 Sep;17(1):5-13
pubmed: 8541250
J Clin Psychol. 2014 Apr;70(4):303-12
pubmed: 24114797
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Schizophr Res. 2012 Sep;140(1-3):37-40
pubmed: 22831771
World Psychiatry. 2008 Oct;7(3):148-56
pubmed: 18836582
Psychiatry Res. 2015 Aug 30;228(3):803-7
pubmed: 26089018
Early Interv Psychiatry. 2013 Aug;7(3):329-37
pubmed: 23848427
Psychiatry. 2006 Summer;69(2):115-29
pubmed: 16822191
BMJ. 2017 Jan 12;356:i6681
pubmed: 28082379
Early Interv Psychiatry. 2017 Aug;11(4):290-295
pubmed: 25808317
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Br J Psychiatry. 2010 May;196(5):372-6
pubmed: 20435962
Psychiatr Serv. 2014 Apr 1;65(4):546-50
pubmed: 24687106
Clin Psychol Psychother. 2011 May-Jun;18(3):250-5
pubmed: 21584907
Psychiatr Serv. 2008 Nov;59(11):1338-42
pubmed: 18971413
Psychol Med. 2012 Mar;42(3):595-606
pubmed: 21854682
Am Psychol. 2006 Nov;61(8):774-788
pubmed: 17115810
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
J Med Internet Res. 2011 Mar 10;13(1):e30
pubmed: 21393123
CNS Drugs. 2016 May;30(5):357-68
pubmed: 27106296
Br J Psychiatry. 2009 Jan;194(1):18-24
pubmed: 19118320
Med Sci Sports Exerc. 2010 Jun;42(6):1094-102
pubmed: 19997030
J Pers Assess. 2011 Sep-Oct;93(5):483-90
pubmed: 21859288
Br J Psychiatry Suppl. 1993 Dec;(22):39-44
pubmed: 8110442
Psychiatry Res. 2008 Nov 30;161(2):213-24
pubmed: 18848731
Epidemiol Psychiatr Sci. 2016 Apr;25(2):123-6
pubmed: 26880239
Arch Gen Psychiatry. 2004 Feb;61(2):143-50
pubmed: 14757590
BMJ. 2005 Sep 17;331(7517):602
pubmed: 16141449
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
Behav Res Ther. 1998 Apr;36(4):455-70
pubmed: 9670605
Am Psychol. 2000 Jan;55(1):68-78
pubmed: 11392867
Schizophr Res. 2000 Nov 30;46(1):25-30
pubmed: 11099882
Schizophr Bull. 2013 Jan;39(1):43-51
pubmed: 21622849
Can J Psychiatry. 2009 Oct;54(10):710-8
pubmed: 19835678
J Abnorm Psychol. 1971 Aug;78(1):107-26
pubmed: 4938262
Psychol Med. 2008 Dec;38(12):1701-15
pubmed: 19000327
Trials. 2017 Jan 17;18(1):27
pubmed: 28095883
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMJ. 2004 Nov 6;329(7474):1067
pubmed: 15485934
Psychiatry Res. 2014 May 30;216(3):412-7
pubmed: 24613006
World Psychiatry. 2017 Oct;16(3):278-286
pubmed: 28941098
Br J Psychiatry. 2010 May;196(5):343-5
pubmed: 20435956
Schizophr Res. 2000 May 5;42(3):241-7
pubmed: 10785582
Psychiatry Res. 1997 Nov 14;73(1-2):73-82
pubmed: 9463840
Am J Psychiatry. 1993 Jun;150(6):873-9
pubmed: 8494061
Psychiatr Serv. 2015 Jul;66(7):764-5
pubmed: 26130154
Psychiatr Serv. 2006 Dec;57(12):1778-83
pubmed: 17158494
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
Schizophr Bull. 2011 May;37(3):619-30
pubmed: 19900962
Schizophr Res. 2005 Dec 15;80(2-3):227-34
pubmed: 15964175
Stat Med. 1999 Aug 15;18(15):1903-42
pubmed: 10440877
Acta Psychiatr Scand. 2000 Nov;102(5):376-85
pubmed: 11098810
Schizophr Res. 2011 Jul;129(2-3):111-5
pubmed: 21549566